First Time Loading...

Venus Remedies Ltd
NSE:VENUSREM

Watchlist Manager
Venus Remedies Ltd Logo
Venus Remedies Ltd
NSE:VENUSREM
Watchlist
Price: 293.7 INR -2.05%
Updated: May 14, 2024
Section:
 

Wall Street
Price Targets

VENUSREM Price Targets Summary
Venus Remedies Ltd

Wall Street analysts forecast VENUSREM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VENUSREM is 395.76 INR with a low forecast of 391.88 INR and a high forecast of 407.4 INR.

VENUSREM Lowest Forecast
Wall Street Target
391.88 INR
33% Upside
VENUSREM Average Forecast
Wall Street Target
395.76 INR
35% Upside
VENUSREM Highest Forecast
Wall Street Target
407.4 INR
39% Upside
Lowest
Price Target
391.88 INR
33% Upside
Average
Price Target
395.76 INR
35% Upside
Highest
Price Target
407.4 INR
39% Upside
Venus Remedies Ltd Competitors:
Price Targets
VETO
Vetoquinol SA
11% Upside
K
102940
Kolon Life Science Inc
497% Upside
A
AQST
Aquestive Therapeutics Inc
185% Upside
HCM
HUTCHMED (China) Ltd
8% Upside
VETO
Vetoquinol SA
11% Upside
K
102940
Kolon Life Science Inc
497% Upside
A
AQST
Aquestive Therapeutics Inc
185% Upside
HCM
HUTCHMED (China) Ltd
8% Upside
NEULANDLAB
Neuland Laboratories Ltd
38% Upside
COLL
Collegium Pharmaceutical Inc
27% Upside
524731
Jenburkt Pharmaceuticals Ltd
33% Downside
SUVENPHAR
Suven Pharmaceuticals Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Venus Remedies Ltd

For the last 8 years the compound annual growth rate for Venus Remedies Ltd's revenue is 2%. The projected CAGR for the next 3 years is 15%.

2%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Venus Remedies Ltd

Operating Income forecast
is not available for
Venus Remedies Ltd

Net Income
Forecast

Net Income Estimate
Venus Remedies Ltd

For the last 8 years the compound annual growth rate for Venus Remedies Ltd's net income is 23%. The projected CAGR for the next 3 years is 24%.

23%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
VENUSREM intrinsic value, competitors valuation, and company profile.
DCF Valuation
VENUSREM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VENUSREM stock valuation using valuation multiples.
Wall Street Estimates
VENUSREM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VENUSREM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VENUSREM's stock price target?
Price Target
395.76 INR

According to Wall Street analysts, the average 1-year price target for VENUSREM is 395.76 INR with a low forecast of 391.88 INR and a high forecast of 407.4 INR.

What is Venus Remedies Ltd's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Venus Remedies Ltd's revenue is 2%. The projected CAGR for the next 3 years is 15%.

What is Venus Remedies Ltd's Net Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Venus Remedies Ltd's net income is 23%. The projected CAGR for the next 3 years is 24%.

ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.